Molecular Assemblies Announces $25.8 Million Series B Financing to Initiate Key Customer Program for Commercial Access to Fully Enzymatic DNA Synthesis March 15, 2022
Molecular Assemblies Awarded NIH Phase I SBIR Grant to Develop a Fully Enzymatic DNA Synthesis Process to Propel Synthetic Biology October 19, 2021
Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access April 15, 2021
Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing March 2, 2021
Molecular Assemblies Appoints Phil Paik, Ph.D., Vice President, Platform Development December 10, 2020
Molecular Assemblies President and CEO to Present at Second Silicon Valley Business Forum December 4, 2020
Molecular Assemblies Announces $12.2 M Series A Financing to Advance Enzymatic DNA Synthesis for Life Sciences and Data Storage October 1, 2019